Form 8-K

8-K — PRECISION OPTICS CORPORATION, INC.

Accession: 0001683168-26-007465

Filed: 2026-09-28

Period: 2026-09-28

CIK: 0000867840

SIC: 3845 (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS)

Item: Results of Operations and Financial Condition

Item: Financial Statements and Exhibits

Documents

8-K — poci_8k.htm (Primary)

EX-99.1 — PRESS RELEASE (poci_ex9901.htm)

GRAPHIC (image_001.jpg)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — CURRENT REPORT

8-K (Primary)

Filename: poci_8k.htm · Sequence: 1

8-K

false

0000867840

2026-09-28

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)

September 28, 2026

PRECISION

OPTICS CORPORATION, INC.

(Exact name of registrant as specified in its charter)

Massachusetts

001-10647

04-2795294

(State or other jurisdiction

(Commission

(IRS Employer

of incorporation)

File Number)

Identification No.)

550 King Street, Bldg. A, Ste. 100

Littleton,

Massachusetts

01460-6245

(Address of principal executive offices)

(Zip Code)

(Registrant’s telephone number, including

area code) (978) 630-1800

Check the appropriate box below if the Form 8-K filing is intended

to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction

A.2. below):

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to

Section 12(b) of the Act:

Title of each class

Trading symbol(s)

Name of each exchange on which registered

Common

stock, par value $0.01 per share

POCI

The Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth

company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange

Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant

has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant

to Section 13(a) of the Exchange Act. ☐

Item 2.02.

Results of Operations and Financial Condition.

On September 28, 2026,

Precision Optics Corporation, Inc. (the “Company”) issued a press release reporting its financial and operating results for

the fourth quarter and fiscal year 2026 with financial guidance for fiscal year 2027 (the “Earnings Release”). A copy of the

Earnings Release is attached hereto as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

None of the information

furnished in this Item 2.02 will be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934,

as amended (the “Exchange Act”), or otherwise subject to the liability of that section, nor will it be deemed incorporated

by reference into any filing under the Securities Act of 1933, as amended (the “Securities Act”).

Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits

Exhibit

No.

Description

99.1

Earnings Release issued by Precision Optics Corporation, Inc., dated

September 28, 2026.

104

Cover page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities

Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

PRECISION OPTICS CORPORATION, INC.

Dated: September 28, 2026

By:

/s/ Joseph N. Forkey

Name: Joseph N. Forkey

Title: President

EX-99.1 — PRESS RELEASE

EX-99.1

Filename: poci_ex9901.htm · Sequence: 2

Exhibit 99.1

PRECISION OPTICS CORPORATION

550 King Street, Bldg. A, Suite 100

Littleton, MA 01460

978 / 630-1800

NEWS RELEASE

POC26-0012

FOR IMMEDIATE RELEASE

Monday, September 28, 2026

Precision Optics

Reports Fourth Quarter and Fiscal Year 2026 Financial Results

Conference Call Scheduled for Today, September

28, 2026, at 5:00 p.m. ET

LITTLETON, MA, September 28, 2026. Precision Optics Corporation, Inc.

(NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries,

today announced financial results for its fourth quarter and fiscal year ended June 30, 2026.

Q4 2026 Financial Highlights (3 Months Ended June 30, 2026)

• Revenue was $8.8 million, a quarterly record, compared to $6.2 million in the same quarter of the previous fiscal year, representing

growth of approximately 42%, and compared to $8.7 million in the most recent sequential quarter.

• Production revenue was $8.0 million, a quarterly record, compared to $5.1 million in the same quarter of the previous fiscal year,

representing growth of approximately 57%, and compared to $7.6 million in the most recent sequential quarter.

• Gross margin was 25.3% compared to 13.0% in the same quarter of the previous fiscal year and compared to 23.6% in the most recent

sequential quarter.

• Net loss for the quarter was $(0.1) million, compared to a net loss of $(1.4) million in the same quarter of the previous fiscal year

and a net loss of $(0.1) million in the most recent sequential quarter.

• Adjusted EBITDA was $0.4 million for the quarter compared to $(0.9) million in the same quarter of the previous fiscal year and $0.3

million in the most recent sequential quarter.

FY 2026 Financial Highlights (Year Ended June 30, 2026)

• Revenue was $31.5 million, a fiscal year record, compared to $19.1 million in the previous fiscal year, representing growth of approximately

65%.

• Production revenue doubled to $28.1 million compared to $14.2 million in the previous fiscal year.

• Gross margin was 17.2% compared to 17.8% in the previous fiscal year.

• Net loss for the fiscal year declined to $(3.6) million, or $(0.43) per share, from $(5.8) million, or $(0.85) per share, in the previous

fiscal year.

• Adjusted EBITDA was $(2.1) million for the fiscal year compared to $(3.7) million in the previous fiscal year, an improvement of approximately

$1.6 million.

• Cash and cash equivalents were $9.8 million at June 30, 2026, compared to $1.8 million at June 30, 2025.

Recent Additional Highlights

• Achieved record quarterly revenue from the Company’s existing top-tier aerospace customer and continued strong production of

its single-use cystoscopy surgery system.

• Continued ramping production under the previously announced $3.5 million follow-on order for the single-use ophthalmic program.

• Received a $1.3 million follow-on production order from a large defense company.

• Recently announced an initial engineering order from a U.S. space technology company.

• Continued strengthening the Company’s leadership team with the appointment of Peter Thier as Senior Vice President of Sales

and Marketing.

FY 2027 Financial Guidance (Year Ending June 30, 2027)

• The Company expects fiscal year 2027 revenue to be in the range of $30

million to $33 million, similar to fiscal year 2026. The outlook reflects a pause in demand from the Company’s existing satellite

customer with growth in single-use medical device programs, renewed defense production, additional programs transitioning into production

and new engineering engagements expecting to partly offset this reduction. The Company expects a stronger second half of the year as orders

are expected to resume from the existing satellite customer.

• The Company expects fiscal year 2027 Adjusted EBITDA to be in a range of $(1.2) million to $(1.7) million.

“Fiscal 2026 was a year of transformation for Precision Optics,

and our fourth-quarter results demonstrate the progress we have made. We delivered record quarterly revenue, and a second consecutive

quarter of positive Adjusted EBITDA, closing a year in which revenue grew 65%,” said Joe Forkey, CEO of Precision Optics. “Our

fiscal 2027 revenue guidance is significantly impacted by the temporary pause in production with our existing satellite customer. As that

customer resumes orders and we execute on growing existing and new customers, we anticipate returning to record quarterly revenue levels

in the second half of the fiscal year. We believe there is a significant market opportunity, and we will continue to invest in capabilities,

capacity and market penetration.”

“Rebuilding our product development pipeline is a priority led

by our new SVP of Sales and Marketing. We received an initial engineering order from a second satellite customer. Although it is still

early, we see the potential to build another meaningful, long-term production relationship.”

The following table summarizes the fourth quarter and fiscal year results

for the periods ended June 30, 2026 and 2025. Fourth-quarter results are unaudited.

Three Months

Ended June 30

2026

Three Months

Ended June 30

2025

Year Ended

June 30

2026

Year Ended

June 30

2025

Revenues

$8,774,474

$6,181,342

$31,531,765

$19,091,269

Cost of goods sold

6,550,806

5,382,155

26,100,545

15,686,836

Gross profit

2,223,668

799,187

5,431,220

3,404,433

Total operating expenses

2,330,228

2,155,229

8,939,828

8,955,724

Operating income (loss)

(106,560)

(1,356,042)

(3,508,608)

(5,551,291)

Interest income (expense), net

(971)

(44,577)

(116,325)

(227,019)

Income (loss) before income taxes

(107,531)

(1,400,619)

(3,624,933)

(5,778,310)

Income tax expense (benefit)

(3,744)

1,936

4,958

1,936

Net Loss

$(103,787)

$(1,402,555)

$(3,629,891)

$(5,780,246)

Earnings (loss) per share, basic

$(0.01)

$(0.18)

$(0.43)

$(0.85)

Earnings (loss) per share, diluted

$(0.01)

$(0.18)

$(0.43)

$(0.85)

Weighted average shares, basic

10,943,843

7,690,084

8,530,599

6,790,466

Weighted average shares, diluted

10,943,843

7,690,084

8,530,599

6,790,466

Conference Call Details

Date and Time: Monday, September 28, 2026, at 5:00 p.m. ET.

Call-in Information: Interested parties can access the conference call

by dialing (844) 735-3662 or (412) 317-5705.

Live Webcast Information: Interested parties can access the conference

call via a live webcast, which will be available at https://app.webinar.net/0E4e7l07PjV.

A teleconference replay of the call will be available for seven days

at (855) 669-9658 or (412) 317-0088, replay access code 7128172. A webcast replay will be available at https://app.webinar.net/0E4e7l07PjV.

About Precision Optics Corporation

Founded in 1982, Precision Optics is a vertically integrated optics

company focused on leveraging its proprietary micro-optics, multi-channel and ultra-high precision imaging and digital imaging technologies

across the medical device, defense/aerospace and satellite communications markets. Through its Systems Manufacturing, Engineering, Ross

Optical and Micro-Optics Lab operations, the Company provides services from new product concept and design through volume production.

Its in-house optical, mechanical, electrical and systems engineering, prototyping, regulatory support, fabrication, assembly and manufacturing

capabilities enable it to develop next-generation solutions for demanding customer requirements. In medical devices, Precision Optics

supports minimally invasive and robotic surgery with micro-endoscopes, single-use and reusable endoscopes, digital imaging and related

optical assemblies. In defense/aerospace and satellite communications, the Company applies its micro-optics and opto-mechanical expertise

to applications requiring high quality and optimized size, weight and power. Ross Optical complements these capabilities through global

sourcing, inspection and production of custom and catalog optics. For more information, please visit www.poci.com.

Non-GAAP Financial Measures

Precision Optics has provided in this press release financial information

that has not been prepared in accordance with accounting principles generally accepted in the United States of America (“non-GAAP”).

The non-GAAP financial measure is Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization). In addition to these

items, Adjusted EBITDA excludes from Net Income (Loss) the effect of stock-based compensation, interest expense and interest income, depreciation

and amortization and income taxes.

This non-GAAP financial measure assists Precision Optics management

in comparing its operating performance over time because certain items may obscure the underlying business trends and make comparisons

of long-term performance difficult, as they are of a nature and/or size that occur with inconsistent frequency or relate to discrete acquisition

or restructuring plans that are fundamentally different from the ongoing productivity of the Company. Precision Optics management also

believes that presenting this measure allows investors to view its performance using the same measures that the Company uses in evaluating

its financial and business performance and trends.

Non-GAAP financial measures should not be considered in isolation from,

or as a substitute for, financial information calculated in accordance with GAAP. Investors are encouraged to review the reconciliation

of non-GAAP measures to their most directly comparable GAAP financial measures. A reconciliation of the non-GAAP financial measure presented

above to GAAP results has been provided in the financial tables included with this press release.

Precision Optics is unable to provide a reconciliation of forward-looking

Adjusted EBITDA guidance to net income (loss), the most directly comparable GAAP financial measure, without unreasonable efforts because

of the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation, including stock-based

compensation expense, which may vary significantly based on stock price and other factors outside the Company’s control. The unavailable

information could have a significant effect on the Company’s GAAP financial results.

About Forward-Looking Statements

This press release contains forward-looking statements

within the meaning of U.S. federal securities laws including statements concerning our fiscal year 2027 revenue and Adjusted EBITDA guidance,

our expectations regarding customer demand and order resumption, and our anticipated return to record revenue levels. Any statements contained

herein that are not statements of historical fact may be deemed to be forward-looking statements. In addition, any statements that refer

to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking

statements. The words "anticipate," "believe," "continue," "could," "estimate," "expect,"

"intends," "may," "might," "plan," "possible," "potential," "predict,"

"project," "should," "would" and similar expressions may identify forward-looking statements, but the absence

of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this press release are

based on certain assumptions and analyses made by the management of the Company in light of their respective experience and perception

of historical trends, current conditions, and expected future developments and their potential effects on the Company as well as other

factors they believe are appropriate in the circumstances. There can be no assurance that future developments affecting the Company will

be those anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control

of the parties), or other assumptions that may cause actual results or performance to be materially different from those expressed or

implied by these forward-looking statements, including the demand for the Company's products, global supply chains and economic activity

in general and other risks and uncertainties identified in the Company's filings with the SEC. Should one or more of these risks or uncertainties

materialize or should any of the assumptions being made prove incorrect, actual results may vary in material respects from those projected

in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result

of new information, future events, or otherwise, except as may be required under applicable securities laws.

PRECISION OPTICS CORPORATION, INC.

Balance Sheets at June 30, 2026 and 2025

2026

2025

ASSETS

Current Assets:

Cash and cash equivalents

$ 9,841,142

$ 1,773,735

Accounts receivable, net of allowance for credit losses of $108,220 at June 30, 2026 and $80,192 at June 30, 2025

5,944,412

4,336,730

Inventories, net

3,829,414

3,562,112

Prepaid expenses

494,488

385,390

Total current assets

20,109,456

10,057,967

Fixed Assets:

Machinery and equipment

3,410,813

3,385,958

Leasehold improvements

1,226,171

871,356

Furniture and fixtures

645,046

538,428

5,282,030

4,795,742

Less—Accumulated depreciation and amortization

4,394,317

4,261,950

Net fixed assets

887,713

533,792

Operating lease right-of-use asset

2,300,866

141,825

Patents, net

212,889

232,493

Goodwill

8,824,210

Total other assets

11,337,965

9,198,528

TOTAL ASSETS

$ 32,335,134

$ 19,790,287

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current Liabilities:

Current portion of capital lease obligation

$ –

$ 27,368

Current maturities of long-term debt

577,898

Accounts payable

3,582,674

2,909,100

Customer advances

2,498,501

1,821,929

Accrued compensation and other

1,843,368

764,004

Operating lease liability

325,500

50,995

Total current liabilities

8,827,941

6,151,294

Long-term debt, net of current maturities

711,305

1,289,205

Operating lease liability, net of current portion

2,446,576

90,954

Total liabilities

11,985,822

7,531,453

Stockholders’ Equity:

Common stock, $0.01 par value: 50,000,000 shares authorized; issued and outstanding – 10,972,792 shares at June 30, 2026 and 7,714,701 shares at June 30, 2025

109,728

77,147

Additional paid-in capital

80,840,105

69,152,317

Accumulated deficit

(60,600,521 )

(56,970,630 )

Total stockholders’ equity

20,349,312

12,258,834

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

$ 32,335,134

$ 19,790,287

PRECISION OPTICS CORPORATION, INC.

Statements of Operations

for the Years Ended June 30, 2026 and 2025

2026

2025

Revenues

$ 31,531,765

$ 19,091,269

Cost of goods sold

26,100,545

15,686,836

Gross profit

5,431,220

3,404,433

Research and development expenses, net

1,033,156

1,157,963

Selling, general and administrative expenses

7,906,672

7,797,761

Total operating expenses

8,939,828

8,955,724

Operating loss

(3,508,608 )

(5,551,291 )

Other expense

Interest expense

(148,129 )

(227,019 )

Interest income

31,804

–

Loss before provision for income taxes

(3,624,933 )

(5,778,310 )

Provision for income taxes

4,958

1,936

Net loss

$ (3,629,891 )

$ (5,780,246 )

Loss per share:

Basic and fully diluted

$ (0.43 )

$ (0.85 )

Weighted average common shares outstanding:

Basic and fully diluted

8,530,599

6,790,466

PRECISION OPTICS CORPORATION, INC.

Statements of Stockholders’ Equity

for the Years Ended June 30, 2026 and 2025

Number of

Common

Stock

Additional

Paid-in

Capital

Accumulated

Deficit

Total

Stockholders’

Equity

Balance, June 30, 2024

6,073,939

$ 60,739

$ 61,197,433

$ (51,190,384 )

$ 10,067,788

Issuance of common stock in a registered direct offering

1,538,368

15,384

6,254,752

–

6,270,136

Proceeds from exercise of stock option

71,979

721

88,329

–

89,050

Issuance of common stock for consulting services and employees

30,415

303

151,395

–

151,698

Stock-based compensation

–

1,460,408

–

1,460,408

Net loss

–

(5,780,246 )

Balance, June 30, 2025

7,714,701

$ 77,147

$ 69,152,317

$ (56,970,630 )

$ 12,258,834

Issuance of common stock in public offering

3,194,444

31,944

10,598,734

–

10,630,678

Proceeds from exercise of stock option

40,294

404

39,595

–

39,999

Issuance of common stock for employee services

23,353

233

100,267

–

100,500

Stock-based compensation

–

949,192

–

949,192

Net loss

–

(3,629,891 )

Balance, June 30, 2026

10,972,792

$ 109,728

$ 80,840,105

$ (60,600,521 )

$ 20,349,312

PRECISION OPTICS CORPORATION, INC.

Statements of Cash Flows

For the Years Ended June 30, 2026 and 2025

2026

2025

Cash Flows from Operating Activities:

Net loss

$ (3,629,891 )

$ (5,780,246 )

Adjustments to reconcile net loss to net cash (used in) provided by operating activities-

Depreciation and amortization

279,277

212,439

Stock-based compensation expense

1,139,692

1,612,106

Non-cash legal expense

–

34,881

Non-cash interest expense

18,433

11,563

Non-cash operating lease expense

252,336

124

Loss on disposal of fixed assets

34,506

–

Changes in operating assets and liabilities:

Accounts receivable, net

(1,607,682 )

(791,239 )

Inventories

(267,302 )

(694,012 )

Prepaid expenses

(109,098 )

(86,026 )

Accounts payable

673,574

1,511,787

Contract liabilities

676,572

649,579

Accrued compensation and other

989,364

(76,658 )

Net cash used in operating activities

(1,550,219 )

(3,395,702 )

Cash Flows from Investing Activities:

Additional patent costs

(5,564 )

(6,264 )

Proceeds from sale of fixed assets

3,000

–

Purchases of property and equipment

(426,786 )

(227,209 )

Net cash used in investing activities

(429,350 )

(233,473 )

Cash Flows from Financing Activities:

Payment of capital lease obligations

(27,368 )

(41,114 )

Principal payments of long-term debt

(596,333 )

(280,440 )

Payment of debt issuance costs

–

(40,000 )

Repayments on line of credit

–

(1,000,000 )

Gross proceeds from registered direct offerings of common stock

–

6,270,136

Proceeds from public offering of common stock, net

10,630,678

–

Gross proceeds from exercise of stock options

39,999

89,050

Net cash provided by financing activities

10,046,976

4,997,632

Net increase in cash and cash equivalents

8,067,407

1,368,457

Cash and cash equivalents, beginning of year

1,773,735

405,278

Cash and cash equivalents, end of year

$ 9,841,142

$ 1,773,735

Supplemental disclosure of cash flow information:

Cash paid during the year for income taxes

$ 2,600

$ 1,936

Cash paid during the year for interest

$ 129,696

$ 216,456

Leasehold improvements financed by landlord

$ 218,750

$ –

Issuance of common stock for consulting and employee services

$ 100,500

$ 151,698

Stock based compensation for employee services included in accrued compensation and other

$ 90,000

$ –

Operating right-of-use assets obtained in exchange for operating lease liabilities

$ 2,632,584

$ 133,650

PRECISION OPTICS CORPORATION, INC.

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

ADJUSTED

EBITDA

Three Months Ended

Year Ended

June 30

2026

2025

2026

2025

Net Loss (GAAP)

$ (103,787 )

$ (1,402,555 )

$ (3,629,891 )

$ (5,780,246 )

Stock based compensation

397,193

439,873

1,139,692

1,612,106

Depreciation and amortization

64,329

59,226

279,277

212,439

Income Taxes

(3,744 )

1,936

4,958

1,936

Interest Expense

32,775

44,577

148,129

227,019

Interest Income

(31,804 )

–

(31,804 )

–

Adjusted EBITDA (non-GAAP)

$ 354,962

$ (856,943 )

$ (2,089,639 )

$ (3,726,746 )

GRAPHIC

Filename: image_001.jpg · Sequence: 6

Binary file (3066 bytes)

Download image_001.jpg

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 8

v3.26.3

Cover

Sep. 28, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Sep. 28, 2026

Entity File Number

001-10647

Entity Registrant Name

PRECISION

OPTICS CORPORATION, INC.

Entity Central Index Key

0000867840

Entity Tax Identification Number

04-2795294

Entity Incorporation, State or Country Code

Entity Address, Address Line One

550 King Street, Bldg. A

Entity Address, Address Line Two

Ste. 100

Entity Address, City or Town

Littleton

Entity Address, State or Province

Entity Address, Postal Zip Code

01460-6245

City Area Code

(978)

Local Phone Number

630-1800

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common

stock, par value $0.01 per share

Trading Symbol

POCI

Security Exchange Name

NASDAQ

Entity Emerging Growth Company

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration